| Year |
Citation |
Score |
| 2019 |
Jimenez RV, Kuznetsova V, Connelly AN, Hel Z, Szalai AJ. C-Reactive Protein Promotes the Expansion of Myeloid Derived Cells With Suppressor Functions. Frontiers in Immunology. 10: 2183. PMID 31620123 DOI: 10.3389/Fimmu.2019.02183 |
0.338 |
|
| 2018 |
Jimenez RV, Wright TT, Jones NR, Wu J, Gibson AW, Szalai AJ. C-Reactive Protein Impairs Dendritic Cell Development, Maturation, and Function: Implications for Peripheral Tolerance. Frontiers in Immunology. 9: 372. PMID 29556231 DOI: 10.3389/Fimmu.2018.00372 |
0.544 |
|
| 2016 |
Lai W, Tang Y, Huang XR, Ming-Kuen Tang P, Xu A, Szalai AJ, Lou TQ, Lan HY. C-reactive protein promotes acute kidney injury via Smad3-dependent inhibition of CDK2/cyclin E. Kidney International. PMID 27470679 DOI: 10.1016/J.Kint.2016.06.010 |
0.365 |
|
| 2016 |
Pegues MA, McWilliams IL, Szalai AJ. C-reactive protein exacerbates renal ischemia-reperfusion injury: are myeloid derived suppressor cells to blame? American Journal of Physiology. Renal Physiology. ajprenal.00107.2016. PMID 27053688 DOI: 10.1152/Ajprenal.00107.2016 |
0.307 |
|
| 2016 |
Li J, Wei D, McCrory MA, Szalai AJ, Yang G, Li L, Li F, Zhao AZ. Human C-Reactive Protein Impedes Entry of Leptin into the CNS and Attenuates Its Physiological Actions in the CNS. The Biochemical Journal. PMID 26933237 DOI: 10.1042/Bj20151282 |
0.332 |
|
| 2015 |
Wright TT, Jimenez RV, Morgan TE, Bali N, Hou X, McCrory MA, Finch CE, Szalai AJ. Hepatic but Not CNS-Expressed Human C-Reactive Protein Inhibits Experimental Autoimmune Encephalomyelitis in Transgenic Mice. Autoimmune Diseases. 2015: 640171. PMID 26421184 DOI: 10.1155/2015/640171 |
0.36 |
|
| 2015 |
Zhang L, Liu SH, Wright TT, Shen ZY, Li HY, Zhu W, Potempa LA, Ji SR, Szalai AJ, Wu Y. C-reactive protein directly suppresses Th1 cell differentiation and alleviates experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 194: 5243-52. PMID 25917100 DOI: 10.4049/Jimmunol.1402909 |
0.341 |
|
| 2014 |
Szalai AJ, Barnum SR, Ramos TN. Deletion of C-reactive protein ameliorates experimental cerebral malaria? Transactions of the Royal Society of Tropical Medicine and Hygiene. 108: 591-3. PMID 25002461 DOI: 10.1093/Trstmh/Tru098 |
0.344 |
|
| 2014 |
Szalai AJ, McCrory MA, Xing D, Hage FG, Miller A, Oparil S, Chen YF, Mazzone M, Early R, Henry SP, Zanardi TA, Graham MJ, Crooke RM. Inhibiting C-reactive protein for the treatment of cardiovascular disease: promising evidence from rodent models. Mediators of Inflammation. 2014: 353614. PMID 24803739 DOI: 10.1155/2014/353614 |
0.332 |
|
| 2014 |
Tang Y, Huang XR, Lv J, Chung ACK, Zhang Y, Chen JZ, Szalai AJ, Xu A, Lan HY. C-reactive protein promotes acute kidney injury by impairing G1/S-dependent tubular epithelium cell regeneration Clinical Science. 126: 645-659. PMID 24206243 DOI: 10.1042/Cs20130471 |
0.37 |
|
| 2013 |
Pegues MA, McCrory MA, Zarjou A, Szalai AJ. C-reactive protein exacerbates renal ischemia-reperfusion injury. American Journal of Physiology. Renal Physiology. 304: F1358-65. PMID 23535585 DOI: 10.1152/Ajprenal.00476.2012 |
0.32 |
|
| 2012 |
Jones NR, Pegues MA, McCrory MA, Singleton W, Bethune C, Baker BF, Norris DA, Crooke RM, Graham MJ, Szalai AJ. A Selective Inhibitor of Human C-reactive Protein Translation Is Efficacious In Vitro and in C-reactive Protein Transgenic Mice and Humans. Molecular Therapy. Nucleic Acids. 1: e52. PMID 23629027 DOI: 10.1038/Mtna.2012.44 |
0.533 |
|
| 2012 |
Mukerji R, Mirza S, Roche AM, Widener RW, Croney CM, Rhee DK, Weiser JN, Szalai AJ, Briles DE. Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine. Journal of Immunology (Baltimore, Md. : 1950). 189: 5327-35. PMID 23105137 DOI: 10.4049/Jimmunol.1201967 |
0.349 |
|
| 2011 |
Szalai AJ. An about-face for C-reactive protein? Clinical Chemistry. 57: 1351-3. PMID 21821724 DOI: 10.1373/Clinchem.2011.172296 |
0.305 |
|
| 2011 |
Jones NR, Pegues MA, McCrory MA, Kerr SW, Jiang H, Sellati R, Berger V, Villalona J, Parikh R, McFarland M, Pantages L, Madwed JB, Szalai AJ. Collagen-induced arthritis is exacerbated in C-reactive protein-deficient mice. Arthritis and Rheumatism. 63: 2641-50. PMID 21567377 DOI: 10.1002/Art.30444 |
0.518 |
|
| 2011 |
Li ZI, Chung AC, Zhou L, Huang XR, Liu F, Fu P, Fan JM, Szalai AJ, Lan HY. C-reactive protein promotes acute renal inflammation and fibrosis in unilateral ureteral obstructive nephropathy in mice. Laboratory Investigation; a Journal of Technical Methods and Pathology. 91: 837-51. PMID 21383672 DOI: 10.1038/Labinvest.2011.42 |
0.326 |
|
| 2011 |
Hu XZ, Wright TT, Jones NR, Ramos TN, Skibinski GA, McCrory MA, Barnum SR, Szalai AJ. Inhibition of Experimental Autoimmune Encephalomyelitis in Human C-Reactive Protein Transgenic Mice Is FcγRIIB Dependent. Autoimmune Diseases. 2011: 484936. PMID 21151582 DOI: 10.4061/2011/484936 |
0.567 |
|
| 2010 |
Li J, Wang JP, Ghiran I, Cerny A, Szalai AJ, Briles DE, Finberg RW. Complement receptor 1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune adherence. Infection and Immunity. 78: 3129-35. PMID 20439480 DOI: 10.1128/Iai.01263-09 |
0.328 |
|
| 2010 |
Hage FG, Oparil S, Xing D, Chen YF, McCrory MA, Szalai AJ. C-reactive protein-mediated vascular injury requires complement. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 1189-95. PMID 20339115 DOI: 10.1161/Atvbaha.110.205377 |
0.348 |
|
| 2010 |
Lan HY, Szalai AJ. Response to C-Reactive Protein and Cardiovascular Disease: Differences Between Humans and Mice Hypertension. 56. DOI: 10.1161/Hypertensionaha.110.155184 |
0.367 |
|
| 2009 |
Shi Y, Li G, Wang D, Chen M, Fukuoka M, Tejani S, Li M, Dawood F, Szalai AJ, Verma S, Liu PP. Human C-Reactive Protein Paradoxically Protects Against Myocardial Infarction (MI) in Mice: Role of hCRP in Bone Marrow Cell Mobilization Journal of Cardiac Failure. 15: S39. DOI: 10.1016/J.Cardfail.2009.06.290 |
0.317 |
|
| 2008 |
Schelonka RL, Zemlin M, Kobayashi R, Ippolito GC, Zhuang Y, Gartland GL, Szalai A, Fujihashi K, Rajewsky K, Schroeder HW. Preferential use of DH reading frame 2 alters B cell development and antigen-specific antibody production Journal of Immunology. 181: 8409-8415. PMID 19050258 DOI: 10.4049/Jimmunol.181.12.8409 |
0.311 |
|
| 2008 |
Smith SS, Ludwig M, Wohler JE, Bullard DC, Szalai AJ, Barnum SR. Deletion of both ICAM-1 and C3 enhances severity of experimental autoimmune encephalomyelitis compared to C3-deficient mice. Neuroscience Letters. 442: 158-60. PMID 18634851 DOI: 10.1016/J.Neulet.2008.07.005 |
0.372 |
|
| 2008 |
Teoh H, Quan A, Lovren F, Wang G, Tirgari S, Szmitko PE, Szalai AJ, Ward ME, Verma S. Impaired endothelial function in C-reactive protein overexpressing mice. Atherosclerosis. 201: 318-25. PMID 18433756 DOI: 10.1016/J.Atherosclerosis.2008.02.034 |
0.369 |
|
| 2008 |
Xing D, Hage FG, Chen YF, McCrory MA, Feng W, Skibinski GA, Majid-Hassan E, Oparil S, Szalai AJ. Exaggerated neointima formation in human C-reactive protein transgenic mice is IgG Fc receptor type I (Fc gamma RI)-dependent. The American Journal of Pathology. 172: 22-30. PMID 18063701 DOI: 10.2353/Ajpath.2008.070154 |
0.326 |
|
| 2008 |
Mrug M, Zhou J, Woo Y, Cui X, Szalai AJ, Novak J, Churchill GA, Guay-Woodford LM. Overexpression of innate immune response genes in a model of recessive polycystic kidney disease Kidney International. 73: 63-76. PMID 17960140 DOI: 10.1038/Sj.Ki.5002627 |
0.324 |
|
| 2007 |
Li J, Glover DT, Szalai AJ, Hollingshead SK, Briles DE. PspA and PspC minimize immune adherence and transfer of pneumococci from erythrocytes to macrophages through their effects on complement activation. Infection and Immunity. 75: 5877-85. PMID 17923519 DOI: 10.1128/Iai.00839-07 |
0.366 |
|
| 2007 |
Hage FG, Szalai AJ. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. Journal of the American College of Cardiology. 50: 1115-22. PMID 17868801 DOI: 10.1016/J.Jacc.2007.06.012 |
0.306 |
|
| 2007 |
Szalai AJ, Hu X, Adams JE, Barnum SR. Complement in experimental autoimmune encephalomyelitis revisited: C3 is required for development of maximal disease. Molecular Immunology. 44: 3132-6. PMID 17353050 DOI: 10.1016/J.Molimm.2007.02.002 |
0.359 |
|
| 2006 |
Chen K, Li F, Li J, Cai H, Strom S, Bisello A, Kelley DE, Friedman-Einat M, Skibinski GA, McCrory MA, Szalai AJ, Zhao AZ. Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nature Medicine. 12: 425-32. PMID 16582918 DOI: 10.1038/Nm1372 |
0.339 |
|
| 2006 |
Barnum SR, Szalai AJ. Complement and demyelinating disease: no MAC needed? Brain Research Reviews. 52: 58-68. PMID 16443278 DOI: 10.1016/J.Brainresrev.2005.12.002 |
0.361 |
|
| 2006 |
Trion A, Maat Md, Jukema W, Maas A, Offerman E, Havekes L, Szalai A, Laarse Avd, Princen H, Emeis J. Anti-atherosclerotic effect of amlodipine, alone and in combination with atorvastatin, in APOE*3-Leiden/hCRP transgenic mice. Journal of Cardiovascular Pharmacology. 47: 89-95. PMID 16424791 DOI: 10.1097/01.Fjc.0000195603.65858.27 |
0.336 |
|
| 2006 |
Osmers I, Szalai AJ, Tenner AJ, Barnum SR. Complement in BuB/BnJ mice revisited: serum C3 levels and complement opsonic activity are not elevated. Molecular Immunology. 43: 1722-5. PMID 16310250 DOI: 10.1016/J.Molimm.2005.10.004 |
0.343 |
|
| 2006 |
Read RW, Szalai AJ, Vogt SD, McGwin G, Barnum SR. Genetic deficiency of C3 as well as CNS-targeted expression of the complement inhibitor sCrry ameliorates experimental autoimmune uveoretinitis. Experimental Eye Research. 82: 389-94. PMID 16143328 DOI: 10.1016/J.Exer.2005.07.011 |
0.376 |
|
| 2005 |
Wang D, Oparil S, Chen YF, McCrory MA, Skibinski GA, Feng W, Szalai AJ. Estrogen treatment abrogates neointima formation in human C-reactive protein transgenic mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 25: 2094-9. PMID 16051879 DOI: 10.1161/01.Atv.0000179602.85797.3F |
0.334 |
|
| 2005 |
Trion A, Maat MPMd, Jukema JW, Laarse Avd, Maas MC, Offerman EH, Havekes LM, Szalai AJ, Princen HMG, Emeis JJ. No Effect of C-Reactive Protein on Early Atherosclerosis Development in Apolipoprotein E*3-Leiden/Human C-Reactive Protein Transgenic Mice Arteriosclerosis, Thrombosis, and Vascular Biology. 25: 1635-1640. PMID 15920036 DOI: 10.1161/01.Atv.0000171992.36710.1E |
0.378 |
|
| 2005 |
Verschuren L, Kleemann R, Offerman EH, Szalai AJ, Emeis SJ, Princen HM, Kooistra T. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 25: 161-7. PMID 15514207 DOI: 10.1161/01.Atv.0000148866.29829.19 |
0.306 |
|
| 2005 |
Boos LA, Szalai AJ, Barnum SR. Murine complement C4 is not required for experimental autoimmune encephalomyelitis. Glia. 49: 158-60. PMID 15390104 DOI: 10.1002/Glia.20093 |
0.357 |
|
| 2004 |
Ren B, McCrory MA, Pass C, Bullard DC, Ballantyne CM, Xu Y, Briles DE, Szalai AJ. The virulence function of Streptococcus pneumoniae surface protein A involves inhibition of complement activation and impairment of complement receptor-mediated protection. Journal of Immunology (Baltimore, Md. : 1950). 173: 7506-12. PMID 15585877 DOI: 10.4049/Jimmunol.173.12.7506 |
0.328 |
|
| 2004 |
Szalai AJ. C-reactive protein (CRP) and autoimmune disease: facts and conjectures. Clinical & Developmental Immunology. 11: 221-6. PMID 15559367 DOI: 10.1080/17402520400001751 |
0.316 |
|
| 2004 |
Zinn KR, Szalai AJ, Stargel A, Krasnykh V, Chaudhuri TR. Bioluminescence imaging reveals a significant role for complement in liver transduction following intravenous delivery of adenovirus. Gene Therapy. 11: 1482-6. PMID 15295616 DOI: 10.1038/Sj.Gt.3302331 |
0.331 |
|
| 2004 |
Liu W, Szalai A, Zhao L, Liu D, Martin F, Kimberly RP, Zhou T, Carter RH. Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI. Arthritis and Rheumatism. 50: 1884-96. PMID 15188365 DOI: 10.1002/Art.20290 |
0.344 |
|
| 2004 |
Kleemann R, Verschuren L, de Rooij BJ, Lindeman J, de Maat MM, Szalai AJ, Princen HM, Kooistra T. Evidence for anti-inflammatory activity of statins and PPARalpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro. Blood. 103: 4188-94. PMID 14976045 DOI: 10.1182/Blood-2003-11-3791 |
0.342 |
|
| 2004 |
Paul A, Ko KW, Li L, Yechoor V, McCrory MA, Szalai AJ, Chan L. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation. 109: 647-55. PMID 14744975 DOI: 10.1161/01.Cir.0000114526.50618.24 |
0.361 |
|
| 2004 |
Ren B, Szalai AJ, Hollingshead SK, Briles DE. Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface. Infection and Immunity. 72: 114-22. PMID 14688088 DOI: 10.1128/Iai.72.1.114-122.2004 |
0.333 |
|
| 2004 |
Kleemann R, Verschuren L, de Rooij B, Lindeman J, Szalai A, Princen H, Kooistra T. W01.43 Evidence for anti-inflammatory activity of statins and fibrates from studies in human C-reactive protein transgenic mice and in cultured human hepatocytes Atherosclerosis Supplements. 5: 10. DOI: 10.1016/S1567-5688(04)90043-3 |
0.355 |
|
| 2004 |
Zinn KR, Chaudhuri TR, Stargel A, Krasnykh V, Szalai AJ. 1013. Complement Component 3 Facilitates Ad5-Mediated Liver Transfection Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.958 |
0.328 |
|
| 2003 |
Danenberg HD, Szalai AJ, Swaminathan RV, Peng L, Chen Z, Seifert P, Fay WP, Simon DI, Edelman ER. Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice. Circulation. 108: 512-5. PMID 12874178 DOI: 10.1161/01.Cir.0000085568.13915.1E |
0.373 |
|
| 2003 |
Xu Y, Szalai AJ, Zhou T, Zinn KR, Chaudhuri TR, Li X, Koopman WJ, Kimberly RP. Fc gamma Rs modulate cytotoxicity of anti-Fas antibodies: implications for agonistic antibody-based therapeutics. Journal of Immunology (Baltimore, Md. : 1950). 171: 562-8. PMID 12847219 DOI: 10.4049/Jimmunol.171.2.562 |
0.301 |
|
| 2003 |
Szalai AJ, Weaver CT, McCrory MA, van Ginkel FW, Reiman RM, Kearney JF, Marion TN, Volanakis JE. Delayed lupus onset in (NZB x NZW)F1 mice expressing a human C-reactive protein transgene. Arthritis and Rheumatism. 48: 1602-11. PMID 12794828 DOI: 10.1002/Art.11026 |
0.366 |
|
| 2003 |
Princen H, De Rooij B, Szalai A, De Maat M, Kooistra T, Kleemann R. 4P-1178 Direct in vivo down-regulation of IL-1-induced C-reactive protein (CRP) expression by statins and fibrates in human CRP transgenic mice Atherosclerosis Supplements. 4: 334. DOI: 10.1016/S1567-5688(03)91434-6 |
0.353 |
|
| 2002 |
Szalai AJ. The biological functions of C-reactive protein. Vascular Pharmacology. 39: 105-7. PMID 12616974 DOI: 10.1016/S1537-1891(02)00294-X |
0.383 |
|
| 2002 |
Szalai AJ, McCrory MA. Varied biologic functions of C-reactive protein: lessons learned from transgenic mice. Immunologic Research. 26: 279-87. PMID 12403365 DOI: 10.1385/Ir:26:1-3:279 |
0.389 |
|
| 2002 |
Szalai AJ, Nataf S, Hu XZ, Barnum SR. Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein. Journal of Immunology (Baltimore, Md. : 1950). 168: 5792-7. PMID 12023381 DOI: 10.4049/Jimmunol.168.11.5792 |
0.367 |
|
| 2002 |
Szalai AJ. The antimicrobial activity of C-reactive protein. Microbes and Infection / Institut Pasteur. 4: 201-5. PMID 11880053 DOI: 10.1016/S1286-4579(01)01528-3 |
0.387 |
|
| 2000 |
Nataf S, Carroll SL, Wetsel RA, Szalai AJ, Barnum SR. Attenuation of experimental autoimmune demyelination in complement-deficient mice. Journal of Immunology (Baltimore, Md. : 1950). 165: 5867-73. PMID 11067947 DOI: 10.4049/Jimmunol.165.10.5867 |
0.349 |
|
| 2000 |
Szalai AJ, VanCott JL, McGhee JR, Volanakis JE, Benjamin WH. Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice. Infection and Immunity. 68: 5652-6. PMID 10992466 DOI: 10.1128/Iai.68.10.5652-5656.2000 |
0.409 |
|
| 2000 |
Szalai AJ, van Ginkel FW, Wang Y, McGhee JR, Volanakis JE. Complement-dependent acute-phase expression of C-reactive protein and serum amyloid P-component. Journal of Immunology (Baltimore, Md. : 1950). 165: 1030-5. PMID 10878380 DOI: 10.4049/Jimmunol.165.2.1030 |
0.338 |
|
| 2000 |
Szalai AJ, Digerness SB, Agrawal A, Kearney JF, Bucy RP, Niwas S, Kilpatrick JM, Babu YS, Volanakis JE. The Arthus reaction in rodents: species-specific requirement of complement. Journal of Immunology (Baltimore, Md. : 1950). 164: 463-8. PMID 10605043 DOI: 10.4049/Jimmunol.164.1.463 |
0.594 |
|
| 1999 |
Tu AHT, Fulgham RL, Mccrory MA, Briles DE, Szalai AJ. Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae Infection and Immunity. 67: 4720-4724. PMID 10456922 DOI: 10.1128/Iai.67.9.4720-4724.1999 |
0.403 |
|
| 1999 |
Circolo A, Garnier G, Fukuda W, Wang X, Hidvegi T, Szalai AJ, Briles DE, Volanakis JE, Wetsel RA, Colten HR. Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology. 42: 135-49. PMID 10408374 DOI: 10.1016/S0162-3109(99)00021-1 |
0.369 |
|
| 1999 |
Szalai AJ, Agrawal A, Greenhough TJ, Volanakis JE. C-reactive protein: structural biology and host defense function. Clinical Chemistry and Laboratory Medicine. 37: 265-70. PMID 10353470 DOI: 10.1515/Cclm.1999.046 |
0.649 |
|
| 1999 |
O'Brien DP, Briles DE, Szalai AJ, Tu AH, Sanz I, Nahm MH. Tumor necrosis factor alpha receptor I is important for survival from Streptococcus pneumoniae infections Infection and Immunity. 67: 595-601. PMID 9916064 DOI: 10.1128/Iai.67.2.595-601.1999 |
0.344 |
|
| 1997 |
Szalai AJ, Agrawal A, Greenhough TJ, Volanakis JE. C-reactive protein: structural biology, gene expression, and host defense function. Immunologic Research. 16: 127-36. PMID 9212359 DOI: 10.1007/Bf02786357 |
0.648 |
|
| 1996 |
Szalai AJ, Briles DE, Volanakis JE. Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae Infection and Immunity. 64: 4850-4853. PMID 8890251 DOI: 10.1128/Iai.64.11.4850-4853.1996 |
0.399 |
|
| 1994 |
Szalai AJ, Bly JE, Clem LW. Changes in serum concentrations of channel catfish (Ictalurus punctatus Rafinesque) phosphorylcholine-reactive protein (PRP) in response to inflammatory agents, low temperature-shock and infection by the fungus Saprolegnia sp. Fish & Shellfish Immunology. 4: 323-336. DOI: 10.1006/Fsim.1994.1029 |
0.329 |
|
| 1992 |
Szalai AJ, Lysack W, Dick TA. Use of confidence ellipses to detect effects of parasites on the growth of yellow perch, Perca flavescens. Journal of Parasitology. 78: 64-69. DOI: 10.2307/3283688 |
0.661 |
|
| 1991 |
Szalai AJ, Dick TA. Evaluation of gill nets, fyke nets, and mark-recapture methods to estimate the number of Hirudinea and Crustacea on fish. Journal of Parasitology. 77: 914-922. DOI: 10.2307/3282741 |
0.644 |
|
| 1991 |
Szalai AJ, Dick TA. Role of predation and parasitism in growth and mortality of yellow perch in Dauphin Lake, Manitoba. Transactions of the American Fisheries Society. 120: 739-751. DOI: 10.1577/1548-8659(1991)120<0739:Ropapi>2.3.Co;2 |
0.654 |
|
| 1990 |
Szalai AJ, Dick TA. Proteocephalus ambloplitis and Contracaecum sp. from largemouth bass (Micropterus salmoides) stocked into Boundary Reservoir, Saskatchewan. Journal of Parasitology. 76: 598-601. DOI: 10.2307/3282854 |
0.635 |
|
| 1990 |
de Vos T, Szalai AJ, Dick TA. Genetic and morphological variability in a population of Diphyllobothrium dendriticum (Nitzsch, 1824) Systematic Parasitology. 16: 99-105. DOI: 10.1007/Bf00009609 |
0.623 |
|
| 1989 |
Szalai AJ, Yang X, Dick TA. Changes in numbers and growth of Ligula intestinalis in the spottail shiner (Notropis hudsonius), and their roles in transmission. Journal of Parasitology. 75: 571-576. DOI: 10.2307/3282908 |
0.667 |
|
| 1988 |
Szalai AJ, Dick TA. Helminths Of Stocked Rainbow Trout (Salmo Gairdneri) With Special Reference To Clinostomum Complanatum Journal of Wildlife Diseases. 24: 456-460. PMID 3411701 DOI: 10.7589/0090-3558-24.3.456 |
0.677 |
|
| 1988 |
Szalai AJ, Danell GV, Dick TA. Intestinal leakage and precipitating antibodies in the serum of quillback, Carpiodes cyprinus (Lesueur), infected with Neoechinorhynchus carpiodi Dechtiar, 1968 (Acanthocephala: Neoechinorhynchidae). Journal of Parasitology. 74: 415-420. DOI: 10.2307/3282048 |
0.642 |
|
| 1987 |
Szalai AJ, Dick TA. Intestinal pathology and site specificity of the acanthocephalan Neoechinorhynchus carpiodi Dechtiar, 1968, in quillback, Carpiodes cyprinus (Lesueur). Journal of Parasitology. 73: 467-475. DOI: 10.2307/3282123 |
0.64 |
|
| 1987 |
Szalai AJ, Dick TA. Parasites of quillback, Carpiodes cyprinus (LeSueur), from Dauphin Lake, Manitoba, Canada. Journal of Parasitology. 73: 446-447. DOI: 10.2307/3282115 |
0.638 |
|
| Show low-probability matches. |
